Related Experiment Video

Updated: Jul 16, 2026

Alternative Methods for the Detection of Superoxide Anion Generation in Platelets
06:35

Alternative Methods for the Detection of Superoxide Anion Generation in Platelets

Published on: March 29, 2024

Oxidative stress-mediated platelet CD40 ligand upregulation in patients with hypercholesterolemia: effect of

P Pignatelli1, V Sanguigni, L Lenti

  • 1Department of Experimental Medicine and Pathology, University of Rome La Sapienza, Rome, Italy.

Journal of Thrombosis and Haemostasis : JTH
|March 29, 2007
PubMed

Insights

In hypercholesterolemia, platelet CD40L (a protein with inflammatory properties) is upregulated due to oxidative stress. Atorvastatin reduces platelet CD40L by targeting NADPH oxidase, independent of cholesterol reduction.

Area of Science:

  • Cardiovascular Research
  • Platelet Biology
  • Oxidative Stress

Background:

  • CD40L, a protein implicated in inflammation and thrombosis, is elevated in platelets of hypercholesterolemic patients.
  • The precise mechanism driving CD40L upregulation in hypercholesterolemia remains unclear.

Purpose of the Study:

  • To investigate the link between low-density lipoprotein (LDL)-induced oxidative stress and CD40L overexpression in platelets of hypercholesterolemic patients.
  • To determine if statin therapy can mitigate platelet CD40L levels by interfering with platelet oxidative stress.

Main Methods:

  • Compared platelet CD40L and superoxide anion (O(2)*(-)) production in 40 hypercholesterolemic patients and 40 healthy controls.
  • Randomized hypercholesterolemic patients to diet or atorvastatin treatment, measuring variables at baseline and follow-up.
  • Conducted in vitro studies using LDL-treated platelets to assess the role of NADPH oxidase and atorvastatin.

Main Results:

  • Hypercholesterolemic patients exhibited significantly higher platelet CD40L and O(2)*(-) levels compared to controls.
  • Platelet CD40L levels strongly correlated with O(2)*(-) production.
  • Atorvastatin treatment significantly reduced both platelet CD40L and O(2)*(-) levels, whereas diet alone had no effect.
  • In vitro, LDL induced CD40L upregulation via NADPH oxidase, an effect reversed by atorvastatin.

Conclusions:

  • Platelet CD40L upregulation in hypercholesterolemia is mediated by NADPH oxidase-dependent superoxide generation.
  • Atorvastatin effectively downregulates CD40L through an oxidative stress mechanism involving platelet NADPH oxidase.
  • The cholesterol-lowering action of atorvastatin does not appear to be the primary driver of CD40L reduction.
Abstract

More Related Videos

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...